OTCMKTS:NSTM NovelStem International (NSTM) Stock Price, News & Analysis → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free NSTM Stock Alerts $0.06 0.00 (0.00%) (As of 04/26/2024 ET) Add Compare Share Share Today's Range$0.06▼$0.0650-Day Range$0.06▼$0.0752-Week Range$0.06▼$0.28VolumeN/AAverage Volume864 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsSEC FilingsStock AnalysisChartEarningsFinancialsSEC Filings Get NovelStem International alerts: Email Address Ad Weiss RatingsThe Next Step of Their Control Is Here …Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late. About NovelStem International Stock (OTCMKTS:NSTM)NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is based in Boca Raton, Florida.Read More NSTM Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NSTM Stock News HeadlinesJuly 13, 2023 | finance.yahoo.comArbitration Confirms NovelStem Joint Venture's Rights to Exploit 'Tom Clancy's Net Force' Franchise Globally via Film, TV, Online, Streaming, Gaming and MerchandisingApril 24, 2023 | forbes.comGlencore InternationalApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.March 31, 2023 | finance.yahoo.comNovelStem, Focused on a Patented Genetic Platform Technology for Anti-Cancer Therapies, Reports 2022 Results on Form 10-KDecember 14, 2022 | finance.yahoo.comNovelStem's Affiliate NewStem Announced New Collaboration to Validate Its Software Diagnostic Device for Two Oncology Indications and Two TherapiesOctober 20, 2022 | finance.yahoo.comNovelStem International Corp. (NSTM)October 13, 2022 | finance.yahoo.comNovelStem Now an SEC-Reporting Company, Secures Commitment for up to $600K in Bridge Funding, Provides Financial UpdateAugust 27, 2022 | reuters.comNovelstem International CorpApril 26, 2024 | Weiss Ratings (Ad)Protect Yourself While There’s Still Time …The next step of the Fed's control is here. Section 702 of the Foreign Intelligence Surveillance Act was renewed for two more years and passed into law earlier this week. Allowing the Fed to tighten its grip on your personal privacy and freedom.April 15, 2022 | yahoo.comBreast cancer survivor says her sports bra saved her lifeApril 14, 2022 | yahoo.com9 Things That Millennials Who Grew Up In Puerto Rico Will RememberApril 14, 2022 | yahoo.comLatinx People Are Sharing Are Sharing "Untraditional" Beauty Tips From Their Abuelas And Moms, And I'm Taking NotesApril 11, 2022 | finance.yahoo.comNovelStem Announces FDA Pre-Submission and EMA In Vitro Diagnostic Device Filing for Revolutionary Life-Saving, Treatment-Changing Diagnostic Device by 30%-Owned NewStem, LtdFebruary 17, 2022 | yahoo.comCampaigns With Heart Honored As 2022 Halo Award FinalistsFebruary 17, 2022 | yahoo.comMedi-Weightloss Celebrates Growth and Prepares for Expansion in 2022February 15, 2022 | finance.yahoo.comNovelStem Reviews Efforts to Maximize Value from Legacy Entertainment AssetJanuary 23, 2022 | nasdaq.comNovelStem International Corp (NSTM)See More Headlines Receive NSTM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for NovelStem International and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Retail stores, not elsewhere classified Sub-IndustryN/A Current SymbolOTCMKTS:NSTM CUSIPN/A CIK912544 Webwww.novelstem.com Phone410-654-3315Fax561-998-2974Employees15Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,190,000.00 Net MarginsN/A Pretax Margin-32,375.00% Return on Equity-2,613.09% Return on Assets-195.20% Debt Debt-to-Equity RatioN/A Current Ratio0.25 Quick Ratio0.25 Sales & Book Value Annual Sales$10,000.00 Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.04 per share Price / Book1.50Miscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta0.15 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesMr. Jan H. Loeb (Age 65)Executive Chairman & President Mr. Mitchell Rubenstein (Age 70)Co-Founder & Independent Director Ms. Christine Jenkins (Age 60)VP, CFO & Secretary Comp: $54kMr. David CollinsInvestor Relations Firm, Catalyst IRKey CompetitorsENDRA Life SciencesNASDAQ:NDRAiSpecimenNASDAQ:ISPCNovaBay PharmaceuticalsNYSE:NBYAvalon GloboCareNASDAQ:ALBTNemaura MedicalNASDAQ:NMRDView All Competitors NSTM Stock Analysis - Frequently Asked Questions How have NSTM shares performed in 2024? NovelStem International's stock was trading at $0.0629 at the start of the year. Since then, NSTM stock has decreased by 4.6% and is now trading at $0.06. View the best growth stocks for 2024 here. How do I buy shares of NovelStem International? Shares of NSTM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:NSTM) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingHe Is Giving Away BitcoinCrypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchMan Who Predicted 2008: “This Will be Worse.”Altimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NovelStem International Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
